Table 1.
Protocol 2 HRV measurements at the end of study.
| Parameters | Sham |
Ligation |
||
|---|---|---|---|---|
| Sham + shCtrl | Sham + shTLR4 | MI + shCtrl | MI + shTLR4 | |
| No. of surviving rats | 36 | 37 | 43 | 41 |
| HR, bpm | 395 ± 10.2 | 409 ± 14 | 443 ± 18.5* | 422 ± 13.2*,# |
| MAP, mm Hg | 115.24 ± 3.0 | 103.8 ± 4.7 | 91.7 ± 7.7* | 92.1 ± 7.9 |
| LF,nu | 22.52 ± 3.18 | 20.64 ± 4.01 | 41.24 ± 6.06* | 33.91 ± 3.58*,# |
| HF, nu | 88.21 ± 3.52 | 83.96 ± 4.38 | 70.00 ± 5.21* | 77.89 ± 5.09* |
| LF/HF | 0.2462 ± 0.05 | 0.2232 ± 0.03 | 0.5774 ± 0.03* | 0.4179 ± 0.04*,# |
Values are mean ± SD.
HR, heart rate; MAP, mean arterial pressure; LF, low frequency; HF, high frequency; LF/HF, low frequency/high frequency.
*p < 0.05 compared with sham groups.
#p < 0.05 compared with group MI + shCtrl.